Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 39,464 shares at $35.24 ($1.3M) on 2024-11-13, disclosed to the SEC on 2024-11-15.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.24 | 10,803 | $381K | 28.3% |
| 2 | $35.24 | 10,803 | $381K | 28.3% |
| 3 | $32.82 | 8,929 | $293K | 21.7% |
| 4 | $32.82 | 8,929 | $293K | 21.7% |
| Total | $34.14 avg | 39,464 | $1.3M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |